Teresa Carman, MD
- Director, Vascular Medicine, Harrington Heart and Vascular Institute, University Hospitals
- Director, Vascular Medicine, UH Cleveland Medical Center
- Medical Director, Coumadin Clinic, UH Cleveland Medical Center
- Medical Director, Center for Wound Care, UH Cleveland Medical Center
- Assistant Professor, CWRU School of Medicine
- Specialty: Cardiology-Vascular Medicine, Cardiology
-
Location:UH Cleveland Westlake Health Center
960 Clague Rd
Westlake, OH 44145
- Call: 440-250-2060
Biography: Teresa Carman, MD
Expertise
Education
Fellowship | Clinical Thrombosis
Clinical Thrombosis - Cleveland Clinic (2000 - 2001)
Fellowship | Vascular Medicine
Vascular Medicine - Cleveland Clinic (1999 - 2000)
Research Fellowship | Vascular Medicine
Vascular Medicine - Cleveland Clinic Florida (1998 - 1999)
Residency | Internal Medicine
Internal Medicine - Cleveland Clinic Florida (1996 - 1998)
Residency | Transitional Year
Transitional Year - Mayo Clinic (1995 - 1996)
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - Metrohealth Medical Center (1993 - 1994)
Medical Education
The Ohio State University College Of Medicine (1987 - 1992)
Undergraduate
Capital University (1988)
About
Teresa Carman, MD, is a nationally recognized vascular medicine specialist, serving as Director of Vascular Medicine, Medical Director of the Anticoagulation Monitoring Service and Medical Director of the Center for Wound Care at University Hospitals Harrington Heart & Vascular Institute. In addition, she is an assistant professor at Case Western Reserve University School of Medicine.
Dr. Carman earned her medical degree from the Ohio State University College of Medicine. She then completed her residency in internal medicine before pursuing postdoctoral fellowships in vascular medicine and clinical thrombosis. She is also a registered certified physician in vascular interpretation.
In addition to her clinical practice, Dr. Carman has authored more than 60 publications and book chapters on topics related to vascular disease interventions. She is an avid educator and researcher, serving as principal investigator for multiple clinical trials and providing over 150 invited lectures aimed at improving care of patients with vascular conditions. She is the program director for the vascular medicine fellowship at University Hospitals Harrington Heart & Vascular Institute.
Dr. Carman is a director on the American Board of Venous and Lymphatic Medicine, also serving as the chair of the education committee and member of the fellowship oversight and accreditation committee. She is an active member of many national organizations and has served on committees for the American Venous Forum (AVF) and the Society for Vascular Medicine (SVM).
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Teresa Carman did not disclose any Outside Relationships with Industry.